0001758604-21-000001.txt : 20211222 0001758604-21-000001.hdr.sgml : 20211222 20211222124547 ACCESSION NUMBER: 0001758604-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20211222 DATE AS OF CHANGE: 20211222 EFFECTIVENESS DATE: 20211222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Good Therapeutics, Inc. CENTRAL INDEX KEY: 0001758604 IRS NUMBER: 811139952 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-426282 FILM NUMBER: 211512383 BUSINESS ADDRESS: STREET 1: 4317 DENSMORE AVE. N. CITY: SEATTLE STATE: WA ZIP: 98103 BUSINESS PHONE: 425-591-9641 MAIL ADDRESS: STREET 1: 4317 DENSMORE AVE. N. CITY: SEATTLE STATE: WA ZIP: 98103 D 1 primary_doc.xml X0708 D LIVE 0001758604 Good Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 SEATTLE WA WASHINGTON 98102 206-888-8485 DELAWARE None None Corporation true 2016 John Mulligan c/o Good Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Executive Officer Director Promoter John McKearn c/o Good Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Karl Handelsman c/o Good Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Monique Schiersing c/o Good Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Nicholas Walrod c/o Good Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Director Diane Hollenbaugh c/o Good Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Executive Officer Neela Patel c/o Good Therapeutics, Inc. 1616 Eastlake Avenue East, Suite 400 Seattle WA WASHINGTON 98102 Executive Officer Biotechnology Decline to Disclose 06b false 2021-12-08 false true false 0 26439316 8813099 17626217 false 5 0 0 0 false Good Therapeutics, Inc. /s/ John Mulligan John Mulligan Chief Executive Officer 2021-12-22